Article Information
History
- January 29, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- João Pedro Ferrari-Souza1,2,
- Pâmela C. Lukasewicz Ferreira1,
- Bruna Bellaver1,
- Cécile Tissot1,3,
- Yi-Ting Wang3,
- Douglas T. Leffa4,
- Wagner S. Brum2,5,6,
- Andréa L. Benedet3,5,
- Nicholas J. Ashton5,6,7,8,
- Marco Antônio De Bastiani2,
- Andréia Rocha2,
- Joseph Therriault3,
- Firoza Z. Lussier3,
- Mira Chamoun3,
- Stijn Servaes3,
- Gleb Bezgin3,
- Min Su Kang3,
- Jenna Stevenson3,
- Nesrine Rahmouni3,
- Vanessa Pallen3,
- Nina Margherita Poltronetti3,
- William E. Klunk1,
- Dana L. Tudorascu1,
- Annie Cohen1,
- Victor L. Villemagne1,
- Serge Gauthier3,
- Kaj Blennow5,6,
- Henrik Zetterberg5,6,9,10,11,
- Diogo O. Souza2,
- Thomas K. Karikari1,5,6,
- Eduardo R. Zimmer2,12,13,†,
- Pedro Rosa-Neto3,† and
- Tharick A. Pascoal1,*,†
- 1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
- 2Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- 3Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
- 4ADHD Outpatient Program & Development Psychiatry Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
- 5Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- 6Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
- 7Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden
- 8Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
- 9Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK
- 10UK Dementia Research Institute at UCL, London, UK
- 11Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
- 12Department of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- 13Graduate Program in Biological Sciences: Pharmacology and Therapeuctis, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- ↵*Correspondence to Tharick A. Pascoal, MD, PhD., Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA, 3501 Forbes Avenue – Oxford Building, 15213, Pittsburgh, PA, USA, E-mail: PASCOAL{at}pitt.edu / Tel: (+1) 412-246-5147
↵† Senior authors contributed equally to this work.
Posted January 29, 2022.
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
